Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ligand Pharmaceuticals (LGNYZ) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Ligand Pharmaceuticals (LGNYZ) over the last 16 years, with Q3 2025 value amounting to $833000.0.

  • Ligand Pharmaceuticals' Other Non Operating Income rose 10879.99% to $833000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$41.6 million, marking a year-over-year increase of 166.38%. This contributed to the annual value of -$54.9 million for FY2024, which is 312667.45% down from last year.
  • According to the latest figures from Q3 2025, Ligand Pharmaceuticals' Other Non Operating Income is $833000.0, which was up 10879.99% from $1.4 million recorded in Q2 2025.
  • In the past 5 years, Ligand Pharmaceuticals' Other Non Operating Income ranged from a high of $2.9 million in Q4 2023 and a low of -$41.3 million during Q4 2024
  • In the last 5 years, Ligand Pharmaceuticals' Other Non Operating Income had a median value of -$873000.0 in 2023 and averaged -$4.8 million.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first soared by 96118.72% in 2021, then tumbled by 373997.71% in 2024.
  • Over the past 5 years, Ligand Pharmaceuticals' Other Non Operating Income (Quarter) stood at -$2.1 million in 2021, then soared by 62.84% to -$793000.0 in 2022, then surged by 461.66% to $2.9 million in 2023, then crashed by 1540.48% to -$41.3 million in 2024, then soared by 102.02% to $833000.0 in 2025.
  • Its Other Non Operating Income was $833000.0 in Q3 2025, compared to $1.4 million in Q2 2025 and -$2.5 million in Q1 2025.